Venetoclax plus modified-intensity Idarubicin and Cytarabine treatment as first-line treatment for newly diagnosed pediatric acute myeloid leukemia.
Wang S, Jiang M, Wang Y, Chang L, Zhao B, Liu X, Qi B, Wang S, Liu T, Zhang X, Chen Y, Liu F, Guo Y, Chen X, Zhang L, Zou Y, Yang W, Gao J, Zhu X, Ruan M.
Wang S, et al. Among authors: gao j.
Clin Cancer Res. 2025 Apr 28. doi: 10.1158/1078-0432.CCR-25-0479. Online ahead of print.
Clin Cancer Res. 2025.
PMID: 40293351